These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Nov 11
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies38
- 7D0.8%
- 3M2.6%
- 1Y-7.5%
- YTD-6.1%
Over the last 7 days, the Pharma industry has dropped 2.1%, driven by pullbacks in China Resources Pharmaceutical Group and Grand Pharmaceutical Group of 2.2% and 4.2%, respectively. The industry has fallen 9.4% in the last year. Earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | HK$440.0b | HK$462.8b | HK$31.4b | 8.4x | 14x | 1x |
| Sat, 19 Oct 2024 | HK$503.8b | HK$472.0b | HK$32.8b | 7.8x | 15.4x | 1.1x |
| Mon, 16 Sep 2024 | HK$430.7b | HK$474.3b | HK$32.9b | 7.3x | 13.1x | 0.9x |
| Wed, 14 Aug 2024 | HK$441.6b | HK$463.0b | HK$32.9b | 7.5x | 13.4x | 1x |
| Fri, 12 Jul 2024 | HK$425.5b | HK$458.0b | HK$32.5b | 7.4x | 13.1x | 0.9x |
| Sun, 09 Jun 2024 | HK$474.5b | HK$463.7b | HK$33.9b | 8.4x | 14x | 1x |
| Tue, 07 May 2024 | HK$478.7b | HK$465.0b | HK$33.8b | 8.1x | 14.1x | 1x |
| Thu, 04 Apr 2024 | HK$447.1b | HK$465.0b | HK$36.5b | 7.6x | 12.3x | 1x |
| Sat, 02 Mar 2024 | HK$446.1b | HK$470.8b | HK$33.5b | 7.9x | 13.3x | 0.9x |
| Mon, 29 Jan 2024 | HK$418.0b | HK$472.4b | HK$33.8b | 7x | 12.4x | 0.9x |
| Wed, 27 Dec 2023 | HK$464.0b | HK$472.6b | HK$33.8b | 7.5x | 13.7x | 1x |
| Fri, 24 Nov 2023 | HK$517.2b | HK$472.7b | HK$32.4b | 7.1x | 16x | 1.1x |
| Sun, 22 Oct 2023 | HK$422.4b | HK$469.0b | HK$31.5b | 6.7x | 13.4x | 0.9x |
| Tue, 19 Sep 2023 | HK$430.0b | HK$469.4b | HK$31.6b | 6.8x | 13.6x | 0.9x |
| Thu, 17 Aug 2023 | HK$436.4b | HK$445.5b | HK$28.1b | 8.9x | 15.6x | 1x |
| Sat, 15 Jul 2023 | HK$481.2b | HK$447.6b | HK$28.0b | 9.4x | 17.2x | 1.1x |
| Mon, 12 Jun 2023 | HK$512.9b | HK$448.2b | HK$27.9b | 9.2x | 18.4x | 1.1x |
| Wed, 10 May 2023 | HK$552.7b | HK$453.0b | HK$28.4b | 9x | 19.5x | 1.2x |
| Fri, 07 Apr 2023 | HK$544.0b | HK$453.0b | HK$28.9b | 9.4x | 18.8x | 1.2x |
| Sun, 05 Mar 2023 | HK$606.4b | HK$443.5b | HK$34.0b | 12x | 17.8x | 1.4x |
| Tue, 31 Jan 2023 | HK$628.3b | HK$448.3b | HK$35.8b | 10.5x | 17.6x | 1.4x |
| Thu, 29 Dec 2022 | HK$590.1b | HK$441.7b | HK$34.7b | 10.8x | 17x | 1.3x |
| Sat, 26 Nov 2022 | HK$576.4b | HK$437.9b | HK$34.1b | 9.5x | 16.9x | 1.3x |
| Mon, 24 Oct 2022 | HK$570.5b | HK$511.8b | HK$38.7b | 8.9x | 14.7x | 1.1x |
| Wed, 21 Sep 2022 | HK$511.5b | HK$518.0b | HK$40.5b | 9.2x | 12.6x | 1x |
| Fri, 19 Aug 2022 | HK$570.0b | HK$512.2b | HK$51.2b | 7.9x | 11.1x | 1.1x |
| Sun, 17 Jul 2022 | HK$611.0b | HK$512.6b | HK$51.9b | 8.3x | 11.8x | 1.2x |
| Tue, 14 Jun 2022 | HK$571.1b | HK$514.2b | HK$51.9b | 8.9x | 11x | 1.1x |
| Thu, 12 May 2022 | HK$566.6b | HK$511.7b | HK$51.0b | 8.3x | 11.1x | 1.1x |
| Sat, 09 Apr 2022 | HK$620.8b | HK$525.4b | HK$53.0b | 8.9x | 11.7x | 1.2x |
| Mon, 07 Mar 2022 | HK$640.9b | HK$501.0b | HK$45.2b | 9.4x | 14.2x | 1.3x |
| Wed, 02 Feb 2022 | HK$665.3b | HK$497.2b | HK$43.8b | 9x | 15.2x | 1.3x |
| Fri, 31 Dec 2021 | HK$697.2b | HK$496.9b | HK$43.8b | 9.6x | 15.9x | 1.4x |
| Sun, 28 Nov 2021 | HK$683.4b | HK$495.9b | HK$43.7b | 9.3x | 15.6x | 1.4x |
Price to Earnings Ratio
15.6x
Current Industry PE
- Investors are relatively neutral on the Hong Kong Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 14.7x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.93x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 10% per year over the last three years,
- Revenues have also declined 2.3% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 0.42% | |
| Healthcare | 0.11% | |
| Pharma | 0.79% | |
| Pharma | 0.79% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$18.26 | 5.9% +HK$6.1b | 22.1% | PE21.4x | |
| 1177 Sino Biopharmaceutical | HK$3.38 | 2.7% +HK$1.6b | -12.9% | PE26.7x | |
| 1477 Ocumension Therapeutics | HK$5.66 | 11.4% +HK$472.8m | -21.5% | PS13.9x | |
| 1558 YiChang HEC ChangJiang Pharmaceutical | HK$9.54 | 1.6% +HK$132.0m | 3.0% | PE4.7x | |
| 1666 Tong Ren Tang Technologies | HK$5.20 | 2.0% +HK$128.1m | -20.4% | PE9.5x |
